Emergent has announced the expansion of our proprietary NARCANDirect™ online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg. Read more:

As the landscape around the opioid crisis continues to evolve, Emergent’s Amy Shertzer, director, medical affairs, talks about why it's important to be prepared with naloxone to help save a life from opioid poisoning emergencies.

Claire Bryant, senior program manager, workplace wellbeing, at @NSCsafety, talks about the importance of equipping workplaces with naloxone and educating employees on how to administer it.

Naloxone Awareness Day was June 6. Our team was in D.C. in partnership with @VictoriasVoice_ for Naloxone Awareness Day to raise awareness of the importance of naloxone. #VictoriasVoice #NaloxoneAwarenessDay

Emergent will be added to the broad-market Russell 3000® Index, effective after the U.S. market closes on June 27, 2025. Read more:

Emergent awarded a $62.4 million contract modification from the Administration for Strategic Preparedness and Response (ASPR) for our botulism antitoxin. Read more:

.@NSCsafety President and CEO, Lorraine Martin, talks about how important it is for workplaces to consider naloxone a standard safety intervention. #NSM

As our Strategic Manufacturing Partnerships team is at @IAmBiotech to connect with leaders who share our commitment to advancing public health, we're excited to welcome Jon Lenihan as VP of Strategic Manufacturing Services.

Emergent is sponsoring a symposium discussion on pandemic preparedness at this year’s @EDCTP3 Forum in Kigali, Rwanda. Learn more:

As the opioid crisis has evolved, finding ways to address opioid overdoses in the workplace has remained vital to saving more lives. Gay Owens recounts how the crisis has changed and what Emergent is doing to help stem the tide of fatal opioid overdoses in the workplace. #NSM

Connie, an Ojibwe First Nations nurse practitioner, shares how stigma and preconceived notions can put people at risk for opioid overdose.

An early 2023 survey found major gaps in awareness about the availability of naloxone. Since then, Emergent has committed to expanding access to and education around the medication to help reverse more opioid poisonings.

Our team recently partnered with @scibus to organize Preparedness in Action: Securing Europe’s Future Against Health Emergencies, a roundtable bringing together policymakers and experts to explore how Europe is equipping itself for future health emergencies.

Gay Owens, senior director, medical affairs at Emergent, talks about the importance of NARCAN® Nasal Spray gaining over-the-counter status to help save more lives from opioid overdose in the workplace. #NSM

Emergent is proud to sponsor @VictoriasVoice_ Naloxone Awareness Day, to raise naloxone awareness and call for its increased availability to help save more lives from opioid overdose emergencies. #VictoriasVoice #NaloxoneAwarenessDay

Construction workers are more likely to die of drug overdose than workers in any other occupation, building the case for new safety measures including naloxone. Read more:

A 2022 CDC report found that nearly 80% of overdoses among young people occurred in homes, underscoring the need for expanded access to naloxone. Learn more about how you can be prepared to help save a life: #VictoriasVoice #NaloxoneAwarenessDay

A recent paper from the @InstituteGC highlights the need for a focus on biosecurity in today’s interconnected and technologically advancing world. Read the paper here:

Kevin Yeo, director, medical affairs, recently presented a poster on our smallpox antiviral at the 2025 International Poxvirus, Asfarvirus, and Iridovirus Conference.